Revolutionary Noninvasive Technology for Liver Tumor Treatment Unveiled by USA Health

MOBILE, Ala. – USA Health has unveiled a groundbreaking therapy that could change the game for liver cancer treatment in Alabama. The new Edison Histotripsy System is a noninvasive method designed to target and destroy liver tumors.

At the announcement, University of South Alabama President Jo Bonner expressed excitement about the potential impact on patient care. Josh Snow, CEO of University Hospital, emphasized that this innovation represents a significant shift in treatment options.

The system uses focused ultrasound technology to precisely target tumors without harming surrounding tissues. John Strattmann from HistoSonics, who demonstrated the technology, described it as a “magic show” for its precision and effectiveness. The tumors are essentially liquefied and absorbed by the body, offering hope for patients who previously had limited treatment choices.

Dr. William Richards, chair of surgery at USA Health, pointed out that this therapy is suitable for patients who might be too ill for traditional treatments. It can be performed as an outpatient procedure and even while patients are undergoing chemotherapy. Recovery times are minimal, and complications are notably low.

Another highlight of this therapy is its ability to potentially strengthen the immune system against tumors. Dr. Suzy Figarola, chair of radiology, explained that with follow-up imaging, doctors can monitor the effectiveness of the treatment. Clinical trials are already underway for other organs like the kidney and pancreas.

Over 1,500 patients worldwide have been treated with this innovative approach. USA Health plans to implement histotripsy technology for liver tumors later this summer.

With advancements like this, the future of cancer treatment looks promising, offering new hope where options once seemed scarce.

For more on this therapy, check out the details here.

Source link